StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Elite Pharmaceuticals's market cap was $270.10M on Oct 19, 2026, against $657.04M a year earlier. Over the last 5 years it ranged from $30.34M to $782.04M, with a median of $192.64M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$270.10M-48.7%
2025Dec 31, 2025$526.23M-9.0%
2024Dec 31, 2024$578.04M+307.2%
2023Dec 29, 2023$141.95M+366.7%
2022Dec 30, 2022$30.42M+0.3%
2021Dec 31, 2021$30.34M-39.9%
2020Dec 31, 2020$50.46M-32.7%
2019Dec 31, 2019$74.96M+31.1%
2018Dec 31, 2018$57.18M-19.2%
2017Dec 29, 2017$70.74M-47.2%
2016Dec 30, 2016$134.04M-52.0%
2015Dec 31, 2015$279.11M+105.1%
2014Dec 31, 2014$136.08M+129.2%
2013Dec 31, 2013$59.37M+112.2%
2012Dec 31, 2012$27.97M+56.8%
2011Dec 30, 2011$17.83M–

More Elite Pharmaceuticals figures

See a number that looks wrong?